SCHEMBL13643151

SCHEMBL13643151

C=Cc1cc(OCc2ccccc2)ccc1CCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
MAOB P27338 7/20 0.44
BCHE P06276 4/20 0.43
HTR1D P28221 1/20 0.43
LCK P06239 1/20 0.43
MAOA P21397 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNA4 P43681 1/20 0.43
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
CYP2C19 P33261 1/20 0.41
PTGS2 P35354 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20767526 0.84 ALOX5 (0.50) ALOX5MAOBLCKMAOALMNA
SCHEMBL16956577 0.82 NQO1 (0.42) CYP1A2
SCHEMBL28970950 0.80 MAOB (0.61) ALOX5MAOBBCHECYP4F2CYP4A11
SCHEMBL3920063 0.78 MAOB (0.51) ALOX5MAOBMAOA
SCHEMBL16953704 0.77 ERN1 (0.39) CYP1A2
SCHEMBL5099007 0.77 MAOB (0.56) ALOX5MAOBMAOALMNACYP1A2
SCHEMBL1554121 0.77 ALOX5 (0.51) ALOX5MAOBLCKMAOALMNA
SCHEMBL4829846 0.77 BACE1 (0.54) ALOX5MAOBBCHELCKMAOA
SCHEMBL2617304 0.76 TRPM8 (0.48) MAOBBCHE
SCHEMBL13643153 0.76 CYP4F2 (0.57) ALOX5MAOBBCHEHTR1DCYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772507-B2 Imidazole-benzamide anti-cancer agents CYTOKINETICS, INC. (US) 2014-07-08 US disclosed
US-20130096315-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS QIAN XIANGPING (US) 2013-04-18 US disclosed
US-20120283287-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS QIAN XIANGPING (US) 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283287-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS KIF5B, KIF2C, PLK1 ALOX5 4662/4885MAOB 3045/4885BCHE 3114/4885
US-20130096315-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS KIF5B, KIF2C, PLK1 ALOX5 4646/4885MAOB 2959/4885BCHE 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.